Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JXHL1000315	阿巴卡韦/拉米夫定片	abacavir sulfate;lamivudine	Tablet	Chemical Drugs	Import Drug Application	2010-11-02	葛兰素史克（中国）投资有限公司	GlaxoSmithKline (China) Investment Co Ltd	Certificate Issued	2012-08-03	view
JYHB1700041	阿巴卡韦拉米夫定片	abacavir sulfate;lamivudine	Tablet	Chemical Drugs	Supplementary Application	2017-02-15	葛兰素史克（中国）投资有限公司	GlaxoSmithKline (China) Investment Co Ltd	Certificate Issued	2017-06-28	view
JYHB1500255	阿巴卡韦拉米夫定片	abacavir sulfate;lamivudine	Tablet	Chemical Drugs	Supplementary Application	2015-03-04	葛兰素史克（中国）投资有限公司	GlaxoSmithKline (China) Investment Co Ltd	Certificate Issued	2016-11-15	view
JYHB1400257	阿巴卡韦拉米夫定片	abacavir sulfate;lamivudine	Tablet	Chemical Drugs	Supplementary Application	2014-03-19	葛兰素史克（中国）投资有限公司	GlaxoSmithKline (China) Investment Co Ltd	Certificate Issued	2014-10-10	view
JYHB1201248	阿巴卡韦拉米夫定片	abacavir sulfate;lamivudine	Tablet	Chemical Drugs	Supplementary Application	2012-11-09	葛兰素史克（中国）投资有限公司	GlaxoSmithKline (China) Investment Co Ltd	Certificate Issued	2013-06-25	view
JYHB1701139	阿巴卡韦拉米夫定片	abacavir sulfate;lamivudine	Tablet	Chemical Drugs	Supplementary Application	2017-09-01	葛兰素史克（中国）投资有限公司	GlaxoSmithKline (China) Investment Co Ltd	Filed	2017-09-21	view